Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJSHT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,705
Award facts
- Contract value 100% obligated
- $3,705.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,705.00 to DMS Pharmaceutical Group Inc. for TYPHIM VI 25 MCG/0.5 ML syringes on July 28, 2025, with an ultimate completion date of July 29, 2025. TYPHIM VI is a typhoid vaccine indicated for immunization against typhoid fever, making this delivery order a critical component of the Department of Defense's medical supply chain. The contract carries no set-aside designation, and performance is scheduled at DMS Pharmaceutical Group's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as a primary pharmaceutical distributor for military and federal healthcare facilities nationwide. The company has maintained a robust portfolio of federal contract awards with the Defense Logistics Agency, specializing in the supply of branded and generic prescription drugs, biologics, vaccines, and medical consumables to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FJSHT?
SPE2DB25FJSHT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FJSHT worth?
The government has obligated $3,705 on SPE2DB25FJSHT.
Is contract SPE2DB25FJSHT an order under another contract?
Yes. SPE2DB25FJSHT is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB25FJSHT competed?
The extent of competition for SPE2DB25FJSHT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award